Keywords
regenerative medicine
Argentina
STI policies
regulation
How to Cite
Abstract
In Argentina, scientists and Science, Technology and Innovation (STI) public officials identify stem cells as a strategic priority. This policy definition is translated into a growing state effort to promote capacity building in this technology through programs, funding and debates to generate a specific regulatory framework.
This work aims to explore how state support for research and development (R&D) in stem cells is locally built. With this purpose, we explore the tension between investment in capacity building and the construction of expectations on income revenues, hopes for potential therapeutic applications, and potential risks. We will show how the attempts to generate a specific regulation, driven by actors linked to STI policy seeks to mediate between risk and expectations shaping research and locally developed products for positioning the country as an international benchmark in this emerging technology.
The authors retain the copyright and grant the journal the right to be the first publication of the work, as well as licensing it under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the authorship of the work and publication initial in this magazine. All content is published under the Creative Commons 4.0 international license: Attribution-Non-Commercial-Share Alike.